What is he best known for?
The fields of study Johji Inazawa is best known for:
A significant part of his Cell cycle research incorporates Oncogene and Aurora kinase studies.
In his research, Johji Inazawa performs multidisciplinary study on Oncogene and MAPK/ERK pathway.
His MAPK/ERK pathway study focuses on Dual-specificity phosphatase and p38 mitogen-activated protein kinases.
His study ties his expertise on Cell biology together with the subject of Dual-specificity phosphatase.
Cell biology and p38 mitogen-activated protein kinases are frequently intertwined in his study.
He undertakes multidisciplinary investigations into Aurora kinase and Cell cycle in his work.
Gene and Psychological repression are commonly linked in his work.
He regularly links together related areas like Genetics in his Psychological repression studies.
Genetics connects with themes related to TBX1 in his study.
His most cited work include:
- HSF4, a new member of the human heat shock factor family which lacks properties of a transcriptional activator (338 citations)
- Structural organization of the human oxytocin receptor gene. (198 citations)
- Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation (195 citations)
What are the main themes of his work throughout his whole career to date
Johji Inazawa's looking at Chromosome as part of his Fluorescence in situ hybridization and Gene mapping and Chromosome study.
His work often combines Gene and Fluorescence in situ hybridization studies.
He regularly ties together related areas like Cell cycle in his Genetics studies.
While working on this project, Johji Inazawa studies both Molecular biology and Biochemistry.
He performs integrative Biochemistry and Genetics research in his work.
In his papers, he integrates diverse fields, such as Gene expression and In situ hybridization.
He undertakes multidisciplinary investigations into In situ hybridization and Chromosome in his work.
Johji Inazawa combines Cancer research and Carcinogenesis in his research.
Johji Inazawa incorporates Cancer and Cancer research in his research.
Johji Inazawa most often published in these fields:
- Gene (91.07%)
- Genetics (87.50%)
- Molecular biology (62.50%)
What were the highlights of his more recent work (between 2013-2017)?
- Cancer research (100.00%)
- Genetics (75.00%)
- Cancer (75.00%)
In recent works Johji Inazawa was focusing on the following fields of study:
While working on this project, Johji Inazawa studies both Cancer research and Carcinogenesis.
While working on this project, Johji Inazawa studies both Carcinogenesis and Cancer cell.
Many of his studies on Cancer cell apply to Internal medicine as well.
In his works, Johji Inazawa conducts interdisciplinary research on Internal medicine and Pathology.
While working on this project, Johji Inazawa studies both Pathology and Oncology.
Borrowing concepts from Cancer research, Johji Inazawa weaves in ideas under Oncology.
Borrowing concepts from Molecular biology, he weaves in ideas under Genetics.
He integrates Molecular biology with Gene expression profiling in his research.
He performs multidisciplinary study in the fields of Gene expression profiling and Microarray analysis techniques via his papers.
Between 2013 and 2017, his most popular works were:
- Overexpression of SMYD2 contributes to malignant outcome in gastric cancer (78 citations)
- Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells (43 citations)
- Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer (43 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
